Xue‐qi Liu

1.7k total citations
33 papers, 1.2k citations indexed

About

Xue‐qi Liu is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Xue‐qi Liu has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Nephrology and 10 papers in Epidemiology. Recurrent topics in Xue‐qi Liu's work include Chronic Kidney Disease and Diabetes (11 papers), Autophagy in Disease and Therapy (9 papers) and Renal Diseases and Glomerulopathies (4 papers). Xue‐qi Liu is often cited by papers focused on Chronic Kidney Disease and Diabetes (11 papers), Autophagy in Disease and Therapy (9 papers) and Renal Diseases and Glomerulopathies (4 papers). Xue‐qi Liu collaborates with scholars based in China, United States and Germany. Xue‐qi Liu's co-authors include Ling Jiang, Yonggui Wu, Xiao‐Ming Meng, Li Gao, Yuebo Huang, Han-xu Zeng, Jiagen Wen, Qin Yang, Xiangming Qi and Lei Lei and has published in prestigious journals such as The FASEB Journal, Free Radical Biology and Medicine and Biochemical Pharmacology.

In The Last Decade

Xue‐qi Liu

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xue‐qi Liu China	21	657	330	166	146	141	33	1.2k
Ruizhi Tan China	21	716 1.1×	340 1.0×	179 1.1×	133 0.9×	149 1.1×	73	1.4k
Jiagen Wen China	19	515 0.8×	211 0.6×	145 0.9×	121 0.8×	117 0.8×	47	1.1k
Rongshuang Huang China	18	572 0.9×	447 1.4×	106 0.6×	168 1.2×	164 1.2×	34	1.3k
Rong Wang China	22	482 0.7×	441 1.3×	229 1.4×	86 0.6×	124 0.9×	71	1.3k
Qiuling Fan China	21	622 0.9×	376 1.1×	194 1.2×	193 1.3×	73 0.5×	70	1.3k
Xiaofen Xiong China	16	592 0.9×	285 0.9×	107 0.6×	232 1.6×	94 0.7×	22	1.2k
Haijiang Wu China	18	612 0.9×	220 0.7×	153 0.9×	148 1.0×	95 0.7×	27	1.1k
Feng Guo China	21	729 1.1×	260 0.8×	322 1.9×	208 1.4×	79 0.6×	67	1.4k
Chunling Huang China	21	565 0.9×	200 0.6×	92 0.6×	162 1.1×	118 0.8×	56	1.1k
Jibo Han China	23	869 1.3×	160 0.5×	136 0.8×	191 1.3×	128 0.9×	63	1.5k

Countries citing papers authored by Xue‐qi Liu

Since Specialization

Citations

This map shows the geographic impact of Xue‐qi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐qi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐qi Liu more than expected).

Fields of papers citing papers by Xue‐qi Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐qi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐qi Liu. The network helps show where Xue‐qi Liu may publish in the future.

Co-authorship network of co-authors of Xue‐qi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐qi Liu. A scholar is included among the top collaborators of Xue‐qi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐qi Liu. Xue‐qi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Yu, et al.. (2025). TET 2 Deficiency Exacerbates Podocyte Injury and Mitophagy Disorder in Diabetic Nephropathy by Regulating M 5 C Methylation of Bcas3. The FASEB Journal. 39(19). e70966–e70966. 1 indexed citations

Wang, Yingying, et al.. (2025). Modeling species-specific migration to enhance climate connectivity under climate and anthropogenic stressors. Landscape and Urban Planning. 264. 105468–105468.

Yang, Jia, et al.. (2024). Assessing comprehensive anthropogenic impacts at a regional scale using ecological integrity. Ecological Indicators. 167. 112738–112738. 2 indexed citations

Ma, Yu, et al.. (2024). Rutaecarpine alleviates inflammation and fibrosis by targeting CK2α in diabetic nephropathy. Biomedicine & Pharmacotherapy. 180. 117499–117499. 1 indexed citations

Jiang, Ling, Xue‐qi Liu, Li Gao, et al.. (2022). METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular Therapy. 30(4). 1721–1740. 135 indexed citations

Liu, Zhengjia, et al.. (2022). Compounding soils to improve cropland quality: A study based on field experiments and model simulations in the loess hilly-gully region, China. Journal of Mountain Science. 19(10). 2776–2790. 1 indexed citations

Huang, Yuebo, Ling Jiang, Xue‐qi Liu, et al.. (2022). Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis‐Mediated Ferroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 4776243–4776243. 51 indexed citations

Wang, Xian, Ling Jiang, Xue‐qi Liu, et al.. (2022). Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway. Phytomedicine. 106. 154400–154400. 46 indexed citations

Wang, Xian, et al.. (2022). Clinical Significance of Glomerular Autophagy in Evaluation of Diabetic Kidney Disease Progression. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1945–1959. 9 indexed citations

10.

Lei, Lei, Jing Zhao, Xue‐qi Liu, et al.. (2021). Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways. Drug Design Development and Therapy. Volume 15. 3131–3150. 54 indexed citations

11.

Li, Yuanyuan, Han-xu Zeng, Xue‐qi Liu, et al.. (2021). Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis. International Immunopharmacology. 101(Pt B). 108236–108236. 44 indexed citations

12.

Yang, Qin, Haiyong Chen, Jianan Wang, et al.. (2020). Alcohol promotes renal fibrosis by activating Nox2/4-mediated DNA methylation of Smad7. Clinical Science. 134(2). 103–122. 26 indexed citations

13.

Liu, Xue‐qi, Juan Jin, Zeng Li, et al.. (2020). Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy. Biochemical Pharmacology. 180. 114132–114132. 27 indexed citations

14.

Wang, Jianan, Qin Yang, Chen Yang, et al.. (2020). Smad3 promotes AKI sensitivity in diabetic mice via interaction with p53 and induction of NOX4-dependent ROS production. Redox Biology. 32. 101479–101479. 68 indexed citations

15.

Wang, Jianan, Mingming Liu, Fang Wang, et al.. (2019). RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress. Clinical Science. 133(14). 1609–1627. 67 indexed citations

16.

Zhang, Chong, Chong Zhang, Xue‐qi Liu, et al.. (2018). Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1. International Immunopharmacology. 63. 183–190. 23 indexed citations

17.

Gao, Li, Mingming Liu, Qiuying Ma, et al.. (2018). Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death. Laboratory Investigation. 98(7). 911–923. 45 indexed citations

18.

Yang, Qin, Jianan Wang, Li Gao, et al.. (2018). Nox4 in renal diseases: An update. Free Radical Biology and Medicine. 124. 466–472. 101 indexed citations

19.

Li, Zhonghua, Taoqian Zhao, Xue‐qi Liu, et al.. (2017). Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives. European Journal of Medicinal Chemistry. 143. 1396–1405. 9 indexed citations

20.

Duan, Ying‐Chao, Yuanyuan Guan, Xiaoyu Zhai, et al.. (2016). Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation. European Journal of Medicinal Chemistry. 126. 246–258. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact